BRIEF

on Theranexus (EPA:ALTHX)

Theranexus Unveils 2025 Financial Calendar

Stock price chart of Theranexus (EPA:ALTHX) showing fluctuations.

Theranexus, a biopharmaceutical firm specializing in rare neurological diseases, has disclosed its financial communication schedule for 2025. Each announcement is slated for release post-Euronext market closing. The timeline is tentative and subject to adjustments.

The key dates in the calendar include the cash position announcement as of December 31, 2024, on February 13, 2025. The 2024 annual results and cash position for March 31, 2025, will be shared on April 29, 2025. The Shareholders' General Meeting is set for June 26, 2025. Reports on cash position as of June 30 and September 30 will be presented on July 10 and October 23, respectively, along with the half-year results on September 25, 2025.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Theranexus news